Omori N, Malys M, Woo G, Mansor L
Front Nutr. 2025; 11:1485280.
PMID: 39749357
PMC: 11693454.
DOI: 10.3389/fnut.2024.1485280.
Boer O, Wiker T, Bukhari S, Kjelkenes R, Timpe C, Voldsbekk I
Dev Cogn Neurosci. 2024; 71():101500.
PMID: 39729859
PMC: 11732202.
DOI: 10.1016/j.dcn.2024.101500.
Sjowall D, Stalhand F, Schettini G, Gustavsson P, Hirvikoski T
PLoS One. 2024; 19(12):e0315565.
PMID: 39724222
PMC: 11670939.
DOI: 10.1371/journal.pone.0315565.
Baltes-Flueckiger L, Wagner A, Sattler I, Meyer M, Tschopp A, Walter M
Front Psychol. 2024; 15:1427514.
PMID: 39386141
PMC: 11461187.
DOI: 10.3389/fpsyg.2024.1427514.
Beslot A, Grall-Bronnec M, Balem M, Schreck B, Laforgue E, Victorri-Vigneau C
Harm Reduct J. 2024; 21(1):165.
PMID: 39252018
PMC: 11382469.
DOI: 10.1186/s12954-024-01079-7.
Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders.
Koller D, Mitjans M, Kouakou M, Friligkou E, Cabrera-Mendoza B, Deak J
Psychiatry Res. 2024; 333:115758.
PMID: 38335780
PMC: 11157987.
DOI: 10.1016/j.psychres.2024.115758.
Adult attention-deficit/hyperactivity symptoms and parental cognitions: a meta-analysis.
Miklosi M, Kovacs B, Janovicz J, Lelki F, Kassai R
Front Psychiatry. 2024; 14:1321078.
PMID: 38268568
PMC: 10807045.
DOI: 10.3389/fpsyt.2023.1321078.
Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use.
Johnstad P
Front Public Health. 2024; 11:1268339.
PMID: 38249418
PMC: 10797041.
DOI: 10.3389/fpubh.2023.1268339.
subsp. Probio-M8 alleviates abnormal behavior and regulates gut microbiota in a mouse model suffering from autism.
Miao Z, Chen L, Zhang Y, Zhang J, Zhang H
mSystems. 2023; 9(1):e0101323.
PMID: 38108654
PMC: 10804959.
DOI: 10.1128/msystems.01013-23.
Effects of adolescent methylphenidate administration on methamphetamine conditioned place preference in an animal model of attention-deficit/hyperactivity disorder: Examination of potential sex differences.
Yates J, Broderick M, Berling K, Gieske M, Osborn E, Nelson M
Drug Alcohol Depend. 2023; 252:110970.
PMID: 37748422
PMC: 10615784.
DOI: 10.1016/j.drugalcdep.2023.110970.
Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study.
Vold J, Halmoy A, Chalabianloo F, Pierron M, Loberg E, Johansson K
BMC Psychiatry. 2023; 23(1):479.
PMID: 37386438
PMC: 10308780.
DOI: 10.1186/s12888-023-04980-w.
Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains.
Demontis D, Walters G, Athanasiadis G, Walters R, Therrien K, Nielsen T
Nat Genet. 2023; 55(2):198-208.
PMID: 36702997
PMC: 10914347.
DOI: 10.1038/s41588-022-01285-8.
Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) among Substance Use Disorder (SUD) Populations: Meta-Analysis.
Rohner H, Gaspar N, Philipsen A, Schulze M
Int J Environ Res Public Health. 2023; 20(2).
PMID: 36674031
PMC: 9859173.
DOI: 10.3390/ijerph20021275.
The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review.
Choi W, Woo Y, Wang S, Lim H, Bahk W
PLoS One. 2022; 17(11):e0277175.
PMID: 36331985
PMC: 9635752.
DOI: 10.1371/journal.pone.0277175.
Parental alcohol and drug abuse and offspring mortality by age 10: a population-based register study.
Berg V, Kuja-Halkola R, Khemiri L, Larsson H, Lichtenstein P, Latvala A
Eur J Public Health. 2022; 32(6):933-938.
PMID: 36172920
PMC: 9713384.
DOI: 10.1093/eurpub/ckac142.
Structural brain morphometry as classifier and predictor of ADHD and reward-related comorbidities.
van Rooij D, Zhang-James Y, Buitelaar J, Faraone S, Reif A, Grimm O
Front Psychiatry. 2022; 13:869627.
PMID: 36172513
PMC: 9512052.
DOI: 10.3389/fpsyt.2022.869627.
Sex-related differences in adult attention-deficit hyperactivity disorder patients - An analysis of external globus pallidus functional connectivity in resting-state functional MRI.
Dupont G, van Rooij D, Buitelaar J, Reif A, Grimm O
Front Psychiatry. 2022; 13:962911.
PMID: 36117656
PMC: 9478108.
DOI: 10.3389/fpsyt.2022.962911.
The lived experiences of adults with attention-deficit/hyperactivity disorder: A rapid review of qualitative evidence.
Ginapp C, Macdonald-Gagnon G, Angarita G, Bold K, Potenza M
Front Psychiatry. 2022; 13:949321.
PMID: 36032220
PMC: 9403235.
DOI: 10.3389/fpsyt.2022.949321.
Individual differences in sensitivity to positive home environment among children "at risk" for attention-deficit/hyperactivity disorder: A review.
Einziger T, Berger A
Front Psychiatry. 2022; 13:927411.
PMID: 35935437
PMC: 9353058.
DOI: 10.3389/fpsyt.2022.927411.
Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD.
Tuan W, Babinski D, Rabago D, Zgierska A
Brain Res Bull. 2022; 187:155-161.
PMID: 35839903
PMC: 9279163.
DOI: 10.1016/j.brainresbull.2022.07.005.